Contact this trialFirst, we need to learn more about you.
Alkylating agents
Nemtabrutinib for Chronic Lymphocytic Leukemia
Recruiting2 awardsPhase 3
Springdale, Arkansas
This trial will compare a new drug (nemtabrutinib) to existing treatments for chronic lymphocytic leukemia/small lymphocytic lymphoma, to see if it can prevent progression of the disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service